FDA Approves Unknown Drug — AMIVAS

# FDA Approves AMIVAS New Drug Application The FDA has approved NDA213036 for AMIVAS, marking a significant expansion of the company's product portfolio and positioning it to capture market share in a competitive therapeutic segment. The approval could bolster AMIVAS's revenue streams and enhance its competitive standing, pending commercial launch and market uptake of the new therapeutic option.